Cornell

New York, New York 10065

1 studies enrolling now · 6 studies all time

What they study most

ALL, AML, Acute Lymphoblastic Leukemia (ALL), Blast Crisis, Hodgkin Lymphoma, Hodgkin Lymphoma, Adult, Hodgkin's Lymphoma, Relapsed, Adult, MDS, Mitral Valve Regurgitation (Degenerative or Functional), Multiple Myeloma, Non Hodgkin Lymphoma, Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)

Studies at this site

• TVMR With the INNOVALVE System Trial - Early Feasibility Study — Recruiting now
• Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma — Recruiting now
• Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma — Running, not enrolling
• A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL — Stopped early
• Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients — Completed
• Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies — Completed